Lizzie Ngo is a prominent leader in the biotechnology sector, currently serving as the Founding President of Weaver Biosciences since July 2024. Ngo holds multiple roles, including Director on the Board of Photys Therapeutics and Principal at Longwood Fund, where past positions included Senior Associate. Prior experience includes working as an Associate at Flagship Pioneering and serving as a Postdoctoral Research Associate at the Massachusetts Institute of Technology (MIT), where Ngo led the translation of an anti-cancer drug screening platform and founded an NSF-funded MIT i-Corps team. With a Ph.D. in Biological Engineering from MIT, Ngo has developed innovative cell-based assays and is a named inventor on a worldwide patent application. Educational background includes a Bachelor’s Degree in Genetics and Mathematics from Rutgers University.